COSMOS Pharmaceutical Corporation (3349.T)
JPY 8200.0
(0.76%)
JPY 8200.0
(0.76%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -18.23 Billion JPY | 34.22% |
| 2022 | -27.72 Billion JPY | 0.79% |
| 2021 | -27.94 Billion JPY | 37.42% |
| 2020 | -44.66 Billion JPY | -11.66% |
| 2019 | -40 Billion JPY | -677.17% |
| 2018 | -5.14 Billion JPY | -15.22% |
| 2017 | -4.46 Billion JPY | 24.97% |
| 2016 | -5.95 Billion JPY | -869.71% |
| 2015 | -614 Million JPY | 59.23% |
| 2014 | -1.5 Billion JPY | 89.73% |
| 2013 | -14.66 Billion JPY | -19.76% |
| 2012 | -12.24 Billion JPY | 11.66% |
| 2011 | -13.86 Billion JPY | -21.51% |
| 2010 | -11.4 Billion JPY | -83.16% |
| 2009 | -6.22 Billion JPY | -50.18% |
| 2008 | -4.14 Billion JPY | -153.02% |
| 2007 | -1.63 Billion JPY | -491.17% |
| 2006 | 419 Million JPY | 109.19% |
| 2005 | -4.55 Billion JPY | -1847.44% |
| 2004 | -234 Million JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -24.6 Billion JPY | -34.88% |
| 2023 Q2 | -18.3 Billion JPY | 45.9% |
| 2023 Q3 | -7.74 Billion JPY | 57.68% |
| 2023 Q1 | -33.84 Billion JPY | -22.05% |
| 2023 FY | -18.23 Billion JPY | 34.22% |
| 2023 Q4 | -18.23 Billion JPY | -135.42% |
| 2022 Q1 | -35.72 Billion JPY | -27.83% |
| 2022 Q3 | -18.02 Billion JPY | 30.75% |
| 2022 Q4 | -27.72 Billion JPY | -53.84% |
| 2022 FY | -27.72 Billion JPY | 0.79% |
| 2022 Q2 | -26.02 Billion JPY | 27.15% |
| 2021 Q2 | -36.67 Billion JPY | 18.74% |
| 2021 FY | -27.94 Billion JPY | 37.42% |
| 2021 Q1 | -45.13 Billion JPY | -1.05% |
| 2021 Q3 | -26.81 Billion JPY | 26.89% |
| 2021 Q4 | -27.94 Billion JPY | -4.23% |
| 2020 Q4 | -44.66 Billion JPY | -9.73% |
| 2020 Q3 | -40.7 Billion JPY | -22.01% |
| 2020 FY | -44.66 Billion JPY | -11.66% |
| 2020 Q1 | -39.33 Billion JPY | 1.66% |
| 2020 Q2 | -33.36 Billion JPY | 15.19% |
| 2019 Q3 | -14.11 Billion JPY | -50.5% |
| 2019 FY | -40 Billion JPY | -677.17% |
| 2019 Q1 | -10.14 Billion JPY | -97.18% |
| 2019 Q2 | -9.37 Billion JPY | 7.6% |
| 2019 Q4 | -40 Billion JPY | -183.41% |
| 2018 Q2 | -3.55 Billion JPY | 64.01% |
| 2018 Q4 | -5.14 Billion JPY | -14397.22% |
| 2018 Q3 | 36 Million JPY | 101.01% |
| 2018 Q1 | -9.87 Billion JPY | -121.0% |
| 2018 FY | -5.14 Billion JPY | -15.22% |
| 2017 FY | -4.46 Billion JPY | 24.97% |
| 2017 Q4 | -4.46 Billion JPY | -101.85% |
| 2017 Q3 | -2.21 Billion JPY | 69.14% |
| 2017 Q2 | -7.17 Billion JPY | 47.41% |
| 2017 Q1 | -13.63 Billion JPY | -129.06% |
| 2016 Q1 | -6.47 Billion JPY | -954.07% |
| 2016 Q2 | -4.11 Billion JPY | 36.39% |
| 2016 Q3 | 361 Million JPY | 108.77% |
| 2016 FY | -5.95 Billion JPY | -869.71% |
| 2016 Q4 | -5.95 Billion JPY | -1749.31% |
| 2015 Q4 | -614 Million JPY | -112.81% |
| 2015 FY | -614 Million JPY | 59.23% |
| 2015 Q1 | -6.28 Billion JPY | -317.26% |
| 2015 Q2 | 231 Million JPY | 103.68% |
| 2015 Q3 | 4.79 Billion JPY | 1975.76% |
| 2014 Q4 | -1.5 Billion JPY | 78.57% |
| 2014 FY | -1.5 Billion JPY | 89.73% |
| 2014 Q3 | -7.02 Billion JPY | 34.33% |
| 2014 Q2 | -10.7 Billion JPY | 45.71% |
| 2014 Q1 | -19.71 Billion JPY | -34.41% |
| 2013 FY | -14.66 Billion JPY | -19.76% |
| 2013 Q2 | -9.56 Billion JPY | 23.39% |
| 2013 Q3 | -9.32 Billion JPY | 2.47% |
| 2013 Q4 | -14.66 Billion JPY | -57.2% |
| 2013 Q1 | -12.48 Billion JPY | -1.96% |
| 2012 Q2 | -15.08 Billion JPY | 16.66% |
| 2012 Q1 | -18.09 Billion JPY | -30.55% |
| 2012 Q3 | -7.42 Billion JPY | 50.74% |
| 2012 Q4 | -12.24 Billion JPY | -64.85% |
| 2012 FY | -12.24 Billion JPY | 11.66% |
| 2011 Q3 | -9.62 Billion JPY | 23.7% |
| 2011 Q1 | -14.24 Billion JPY | -24.87% |
| 2011 Q2 | -12.61 Billion JPY | 11.46% |
| 2011 FY | -13.86 Billion JPY | -21.51% |
| 2011 Q4 | -13.86 Billion JPY | -44.04% |
| 2010 Q4 | -11.4 Billion JPY | -71.79% |
| 2010 FY | -11.4 Billion JPY | -83.16% |
| 2010 Q3 | -6.64 Billion JPY | 24.73% |
| 2010 Q2 | -8.82 Billion JPY | 7.11% |
| 2010 Q1 | -9.49 Billion JPY | -52.49% |
| 2009 FY | -6.22 Billion JPY | -50.18% |
| 2009 Q4 | -6.22 Billion JPY | -381.67% |
| 2009 Q3 | -1.29 Billion JPY | 0.0% |
| 2008 Q2 | -1.82 Billion JPY | 0.0% |
| 2008 FY | -4.14 Billion JPY | -153.02% |
| 2008 Q3 | 46 Million JPY | 102.52% |
| 2008 Q4 | -4.14 Billion JPY | -9115.22% |
| 2007 FY | -1.63 Billion JPY | -491.17% |
| 2006 FY | 419 Million JPY | 109.19% |
| 2005 FY | -4.55 Billion JPY | -1847.44% |
| 2004 FY | -234 Million JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| HEARTSEED INC | -4.57 Billion JPY | -298.511% |
| Cawachi Limited | -18.89 Billion JPY | 3.472% |
| Pharmarise Holdings Corporation | 5.64 Billion JPY | 422.854% |
| Qol Holdings Co., Ltd. | 4.93 Billion JPY | 469.34% |
| MatsukiyoCocokara & Co. | -97.05 Billion JPY | 81.209% |
| Welcia Holdings Co., Ltd. | 52.63 Billion JPY | 134.651% |
| Create SD Holdings Co., Ltd. | -37.81 Billion JPY | 51.765% |
| NIHON CHOUZAI Co.,Ltd. | 28.88 Billion JPY | 163.131% |
| Tsuruha Holdings Inc. | -8.51 Billion JPY | -114.162% |
| Ohki Healthcare Holdings Co.,Ltd. | -1.35 Billion JPY | -1242.016% |
| Satudora Holdings Co.,Ltd. | 14.71 Billion JPY | 223.916% |
| Kusuri No Aoki Holdings Co., Ltd. | 49.8 Billion JPY | 136.616% |
| Medical System Network Co., Ltd. | 20.93 Billion JPY | 187.113% |
| Shinnihonseiyaku Co., Ltd. | -15.07 Billion JPY | -21.006% |
| Sugi Holdings Co.,Ltd. | -34.64 Billion JPY | 47.359% |
| YAKUODO HOLDINGS Co., Ltd. | 8.64 Billion JPY | 310.99% |
| Astena Holdings Co., Ltd. | 10.23 Billion JPY | 278.22% |
| Genky DrugStores Co., Ltd. | 24.75 Billion JPY | 173.683% |
| Ain Holdings Inc. | -41.87 Billion JPY | 56.451% |
| Sundrug Co.,Ltd. | -33.84 Billion JPY | 46.113% |